Skip to main content

Advertisement

SpringerLink
Log in

Erectile Dysfunction in the Elderly

  • Geriatric Urology (TJ Guzzo and DJ Canter, Section Editors)
  • Published:
Current Geriatrics Reports Aims and scope Submit manuscript

Abstract

Erectile dysfunction (ED) is a common disorder among older men. In the elderly, chronic comorbidities and the decline of physiologic processes associated with aging combine to impair erectile function. Nevertheless, the desire for sexual activity persists in many older men despite the occurrence of ED, which consequently can have a significant negative impact on quality of life. Multiple safe, efficacious, and convenient options for the treatment of ED have produced excellent results in elderly men, but their application requires an understanding of nuances related to comorbidities, medication interactions, and physical limitations inherent in that population. This review will focus on those nuances, as well as recent advances in the field, with a comprehensive discussion on the epidemiology, pathophysiology, comorbidities, evaluation, and treatment of ED in the elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. National Institutes of Health. Consensus development panel on impotence. JAMA. 1993;270:83–90.

    Article  Google Scholar 

  2. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, D.C.: American Psychological Association; 1994.

  3. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000;12:S6–11.

    Article  PubMed  Google Scholar 

  4. Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol. 2003;169:1999–2007.

    Article  CAS  PubMed  Google Scholar 

  5. Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of “elderly”. Geriatr Gerontol Int. 2006;6:149–58.

    Article  Google Scholar 

  6. Seftel AD. From aspiration to achievement: assessment and noninvasive treatment of erectile dysfunction in aging men. J Am Geriatr Soc. 2005;53:119–30.

    Article  PubMed  Google Scholar 

  7. Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schroder FH, Essink-Bot ML. Erectile dysfunction and mental health in a general population of older men. J Sex Med. 2009;6:505–12.

    Article  PubMed  Google Scholar 

  8. Camacho ME, Reyes-Ortiz CA. Sexual dysfunction in the elderly: age or disease? Int J Impot Res. 2005;17:52–6.

    Article  Google Scholar 

  9. Laumann EO, Glasser DB, Neves RC, Moreira ED. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21:171–8.

    Article  CAS  PubMed  Google Scholar 

  10. De Boer BJ, Bots ML, Nijeholt AA, et al. The prevalence of bother, acceptance, and need for help in men with erectile dysfunction. J Sex Med. 2005;2:445–50.

    Article  PubMed  Google Scholar 

  11. Masters MH, Johnson V. Human sexual response. Boston: Little Brown & Co.; 1966.

    Google Scholar 

  12. Kinsey AC, Pomeroy WB, Martin CE. Sexual behavior in the human male. Philadelphia: WB Saunders; 1948.

    Google Scholar 

  13. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JL. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res. 2002;14:422–32.

    Article  CAS  PubMed  Google Scholar 

  14. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.

    CAS  PubMed  Google Scholar 

  15. Corona G, Lee DM, Forti G, O’Connor DB, Maggi M, O’Neill TW, et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med. 2010;7:1362–80.

    Article  PubMed  Google Scholar 

  16. Marumo K, Nakashima J, Murai M. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol. 2001;8:54–9.

    Google Scholar 

  17. Blanker MH, Bosch JL, Groeneveld FP, Bohnen AM, Prins A, Thomas S, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. J Urol. 2001;54:763–8.

    Article  Google Scholar 

  18. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the “Cologne Male Survey”. Int J Impot Res. 2000;12:305–11.

    Article  CAS  PubMed  Google Scholar 

  19. Parazzini F, Menchini FF, Bortolotti A, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol. 2000;37:43–9.

    Article  CAS  PubMed  Google Scholar 

  20. Moreira ED, Lisboa Lobo CF, Diament A, et al. Incidence of erectile dysfunction in men 40 to 69 years old: results from population-based cohort study in Brazil. J Urol. 2003;61:431–6.

    Article  Google Scholar 

  21. Chew K, Bremner A, Stuckey B, Earle C, Jamrozik K. Sex life after 65: how does erectile dysfunction affect ageing and elderly men? Aging Male. 2009;12:41–6.

    Article  PubMed  Google Scholar 

  22. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50–4.

    Article  CAS  PubMed  Google Scholar 

  23. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, et al. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003;44:245–53.

    Article  CAS  PubMed  Google Scholar 

  24. Shiri R, Koskimäki J, Häkkinen J, et al. Effects of age, comorbidity and lifestyle factors on erectile dysfunction: Tampere Ageing Male Urological Study (TAMUS). Eur Urol. 2004;45:628–33.

    Article  PubMed  Google Scholar 

  25. Mulligan T, Retchin SM, Chinchilli VM, Bettinger CB. The role of aging and chronic disease in sexual dysfunction. J Am Geriatr Soc. 1988;36:520–4.

    CAS  PubMed  Google Scholar 

  26. Lue TF. Erectile dysfunction. New Engl J Med. 2000;342:1802–13.

    Article  CAS  PubMed  Google Scholar 

  27. Albersen M, Orabi H, Lue TF. Evaluation and treatment of erectile dysfunction in the aging male: a mini-review. Gerontology. 2012;58:3–15.

    Article  CAS  PubMed  Google Scholar 

  28. Rowland DL, Greenleaf W, Mas M, et al. Penile and finger sensory thresholds in young, aging, and diabetic males. Arch Sex Behav. 1989;18:1–12.

    Article  CAS  PubMed  Google Scholar 

  29. Hannan JL, Blaser MC, Oldfield L, Pang JJ, Adams SM, Pang SC, et al. Morphological and functional evidence for the contribution of the pudendal artery in aging-induced erectile dysfunction. J Sex Med. 2010;7:3373–84.

    Article  PubMed  Google Scholar 

  30. El-Sakka AI, Yassin AA. Amelioration of penile fibrosis: myth or reality. J Androl. 2010;31:324–35.

    Article  CAS  PubMed  Google Scholar 

  31. Vanhoutte PM. Ageing and endothelial dysfunction. Eur Heart J. 2002;4:A8–17.

    Article  CAS  Google Scholar 

  32. Aversa A, Bruzziches R, Francomano D, Natali M, Gareri P, Spera G. Endothelial dysfunction and erectile dysfunction in the aging man. Int J Urol. 2010;17:38–47.

    Article  PubMed  Google Scholar 

  33. Wespes E. The aging penis. World J Urol. 2002;20:36–9.

    Article  CAS  PubMed  Google Scholar 

  34. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study. J Clin Endocr Metab. 2002;87:589–98.

    Article  CAS  PubMed  Google Scholar 

  35. Tenover JS. Declining testicular function in aging men. Int J Impot Res. 2003;15:S3–8.

    Article  CAS  PubMed  Google Scholar 

  36. Guay A, Velasquez E, Perez J. Characterization of patients in a medical endocrine-based center for male sexual dysfunction. Endocr Pract. 1999;5:314–21.

    Article  CAS  PubMed  Google Scholar 

  37. Traish AM, Munarriz R, O’Connell L, Choi S, Kim SW, Kim NN, et al. Effects of medical or surgical castration on erectile function in an animal model. J Androl. 2003;24:381–7.

    PubMed  Google Scholar 

  38. Aversa A, Isidori A, De Martino M, et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocr. 2000;54:517–22.

    Article  Google Scholar 

  39. Corona G, Mannucci E, Schulman C, et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol. 2006;50:595–604.

    Article  PubMed  Google Scholar 

  40. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols AP. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocr Metab. 2002;87:3632–9.

    Article  CAS  PubMed  Google Scholar 

  41. Corona G, Rastrelli G, Maggi M. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Clin Endocr Metab. 2013;27:557–67.

    CAS  Google Scholar 

  42. Vigen R, O’Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310:1829–36.

    Article  CAS  PubMed  Google Scholar 

  43. Isidori A, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocr. 2005;63:381–94.

    Article  CAS  PubMed  Google Scholar 

  44. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84:108–13.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294:2996–3002.

    Article  CAS  PubMed  Google Scholar 

  46. Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171:1797–803. This work demonstrates that life style modifications may improve erectile function.

    Article  PubMed  Google Scholar 

  47. Kawanishi Y, Lee KS, Kimura K, Koizumi T, Nakatsuji H, Kojima K, et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res. 2001;13:100–3.

    Article  CAS  PubMed  Google Scholar 

  48. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary artery disease correlate with erectile function? Int J Impot Res. 1997;9:123–6.

    Article  CAS  PubMed  Google Scholar 

  49. Corona G, Monami M, Boddi V, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med. 2010;7:1918–27.

    Article  PubMed  Google Scholar 

  50. Roumeguère T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol. 2003;44:355–9.

    Article  PubMed  Google Scholar 

  51. Guiliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7,689 patients with diabetes or hypertension, or both. J Urol. 2004;64:1196–201.

    Article  Google Scholar 

  52. Romeo JH, Seftel AD, Madhum ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol. 2000;163:788–91.

    Article  CAS  PubMed  Google Scholar 

  53. Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson’s disease. J Neuro Sci. 2013;324:17–20.

    Article  Google Scholar 

  54. Perelman MA. Erectile dysfunction and depression: screening and treatment. Urol Clin Nor Am. 2011;38:125–39.

    Article  Google Scholar 

  55. Tang Y, Rampin O, Calas A, et al. Oxytocinergic and serotonergic innervation of identified lumbosacral nuclei controlling penile erection in the male rat. Neuroscience. 1998;82:241–54.

    Article  CAS  PubMed  Google Scholar 

  56. Srilatha B, Adaikan P, Arulkumaran S, et al. Sexual dysfunction related to antihypertensive agents: results from the animal model. Int J Impot Res. 1999;11:107–13.

    Article  CAS  PubMed  Google Scholar 

  57. Lee DM, Tajar A, Ravindrarajah R, Pye SR, O’Connor DB, Corona G, et al. Frailty and sexual health in older European men. Gerontology. 2013;68:837–44. This work supports an independent association between frailty in the elderly and ED.

    Article  Google Scholar 

  58. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. New Engl J Med. 2012;367:203–13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Zelefsky M, Chan H, Hunt M, et al. Long-term outcomes of high intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol. 2006;176:1415–9.

    Article  PubMed  Google Scholar 

  60. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637–49.

    Article  PubMed  Google Scholar 

  61. Wong SY, Leung JC, Woo J. A prospective study on the association between Lower Urinary Tract Symptoms (LUTS) and erectile dysfunction: results from a large study in elderly Chinese in Southern China. J Sex Med. 2009;6:2024–31.

    Article  PubMed  Google Scholar 

  62. Rosen R, Riley A, Wagner G, Osterloh I, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF) a multidimensional scale for assessment of erectile dysfunction. J Urol. 1997;49:822–30.

    Article  CAS  Google Scholar 

  63. Bayraktar Z, Atun AI. Despite some comprehension problems the international index of erectile function is a reliable questionnaire in erectile dysfunction. Urol Int. 2012;88:170–6.

    Article  PubMed  Google Scholar 

  64. Nehra A, Jackson G, Miner M, Billups K, Burnett A, Buvat J, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proceed. 2012;87:766–78. This work contains recommendations for assessing cardiovascular risk prior to initiating therapy for ED.

    Article  Google Scholar 

  65. Muller J, Mittleman M, Maclure M, et al. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular physical exercise. JAMA. 1996;275:1405–9.

    Article  CAS  PubMed  Google Scholar 

  66. Lue TF. Impotence: a patient’s goal-directed approach to treatment. World J Urol. 1990;8:67–74.

    Article  Google Scholar 

  67. Bacon C, Mittleman M, Kawachi M, et al. Sexual function in men older than 50 years of age: results from the Health Professionals Follow-up Study. Ann Intern Med. 2003;139:161–9.

    Article  PubMed  Google Scholar 

  68. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Euro J Endocr. 2013;168:829–43.

    Article  CAS  Google Scholar 

  69. Saltzman E, Guay T, Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol. 2004;172:255–8.

    Article  PubMed  Google Scholar 

  70. Rosen R, Lane R, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharm. 1999;19:67–85.

    Article  CAS  Google Scholar 

  71. Hatzimouratidis K, Hatzichristou D. A comparative review of the options for treatment for erectile dysfunction: which treatment for which patient? Drugs. 2005;65:1621–50.

    Article  CAS  PubMed  Google Scholar 

  72. Albersen M, Shindel A, Mwamukonda K, Lue T. The future is today: emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs. 2010;15:467–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Salonia A, Briganti A, Montorsi P, Maga T, Dehò F, Zanni G, et al. Safety and tolerability of oral erectile dysfunction treatments in the elderly. Drugs Aging. 2005;22:323–38.

    Article  CAS  PubMed  Google Scholar 

  74. Muller A, Smith L, Parker M, Mulhall JP. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population. BJU Int. 2007;100:117–21.

    Article  CAS  PubMed  Google Scholar 

  75. Park K, Ku JH, Kim SW, Paick JS. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int. 2005;95:366–70.

    Article  PubMed  Google Scholar 

  76. Sperling H, Gittelman M, Norenberg C, Ulbrich E, Ewald S. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of Two pivotal trials. J Sex Med. 2011;8:261–71. The work describes the efficacy and safety of orodispersible vardenafil in a strictly elderly population.

    Article  CAS  PubMed  Google Scholar 

  77. Sharlip ID, Shumaker BP, Hakim LS, Goldfischer E, Natanegara F, Wong DG. Tadalafil is efficacious and well tolerated in the treatment of Erectile Dysfunction (ED) in men over 65 years of age: results from multiple observations in men with ED in National Tadalafil Study in the United States. J Sex Med. 2008;5:716–25.

    Article  CAS  PubMed  Google Scholar 

  78. Dong Y, Hao L, Shi Z, et al. Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a meta-analysis. Urol Int. 2013;91:10–8. This work supports the use of tadalafil in the treatment of LUTS in addition to ED.

    Article  CAS  PubMed  Google Scholar 

  79. Goldstein I, Jones L, Belkoff L, et al. Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes. Mayo Clin Proceed. 2012;87:843–52.

    Article  CAS  Google Scholar 

  80. Nehra A, Swearingen D, Dietrich J, et al. Hemodynamic effects of co-administration of avanafil and glyceryl trinitrate. J Sex Med. 2006;3:49.

    Google Scholar 

  81. Kedia G, Uckert S, Assadi-Pour F, et al. Avanafil for the treatment of erectile dysfunction: initial data and key clinical properties. Ther Adv Urol. 2013;5:35–41. This work describes the clinical data relevant to the newest approved medication in the phosphodiesterase inhibitor class.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  82. Guay A, Spark R, Jacobson J, et al. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Int J Impot Res. 2002;14:25–31.

    Article  CAS  PubMed  Google Scholar 

  83. Shindel A, Xin Z, Lin G, et al. Erectogenic and neurotrophic effects of icariin, a purified extract of the horny goat weed in vitro and in vivo. J Sex Med. 2010;7:1518–28.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  84. Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57:804–14.

    Article  PubMed  Google Scholar 

  85. Hellstrom W, Montague D, Moncada I, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010;7:501–23.

    Article  PubMed  Google Scholar 

  86. Chung E, Solomon M, DeYoung L, et al. Clinical outcomes and patient satisfaction rates among elderly male aged ≥75 years with inflatable penile prosthesis implant for medically refractory erectile dysfunction. World J Urol. 2014;32:173–7. This work describes satisfaction with inflatable penile prostheses in a strictly elderly population.

    Article  PubMed  Google Scholar 

  87. Villarreal H, Jones L. Outcome of and satisfaction with the inflatable penile prosthesis in the elderly male. Adv Urol. 2012;2012:4. This work describes satisfaction with inflatable penile prostheses in a strictly elderly population.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Mark S. Hockenberry and Puneet Masson each declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Hospital of the University of Pennsylvania, Division of Urology, Department of Surgery, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd., 3rd Floor, West Pavilion, Philadelphia, PA, 19104, USA

    Mark S. Hockenberry & Puneet Masson

Authors
  1. Mark S. Hockenberry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Puneet Masson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Puneet Masson.

Additional information

This article is part of the Topical Collection on Geriatric Urology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hockenberry, M.S., Masson, P. Erectile Dysfunction in the Elderly. Curr Geri Rep 4, 33–43 (2015). https://doi.org/10.1007/s13670-014-0107-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13670-014-0107-4

Keywords

Search

Navigation